101.96
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$100.48
Aprire:
$100.89
Volume 24 ore:
11.18M
Relative Volume:
1.39
Capitalizzazione di mercato:
$130.09B
Reddito:
$407.94B
Utile/perdita netta:
$2.90B
Rapporto P/E:
44.78
EPS:
2.2771
Flusso di cassa netto:
$7.39B
1 W Prestazione:
+6.29%
1M Prestazione:
+7.16%
6M Prestazione:
+28.38%
1 anno Prestazione:
+53.67%
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CVS
Cvs Health Corp
|
101.96 | 128.21B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
UNH
Unitedhealth Group Inc
|
408.52 | 368.30B | 449.71B | 12.81B | 19.67B | 13.24 |
|
ELV
Elevance Health Inc
|
404.07 | 86.69B | 200.42B | 5.24B | 6.45B | 23.50 |
|
CI
Cigna Group
|
298.00 | 77.99B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
379.22 | 44.27B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS Pharmacy mobile app: health, refills and rewards in one place - AD HOC NEWS
CVS, Humana, and UnitedHealth Face Medicare Advantage Approval C - GuruFocus
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo! Finance Canada
Is CVS (CVS) Using GLP-1 Access and AI Tools to Redefine Its Healthcare Moat? - Yahoo Finance
Danaher Boosts Product Portfolio With the Acquisition of Masimo - Yahoo Finance Australia
CVS Health Corp (CVS) Stock Price, Trades & News - GuruFocus
CVS Health expands Salesforce partnership for AI call centers By Investing.com - Investing.com Canada
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
CVS Health To Deliver Faster, More Personalized Call Center Care for Millions of Members With Salesforce's Agentforce Health - StreetInsider
Sector Gamma AS Buys 21,397 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Te Ahumairangi Investment Management Ltd - MarketBeat
Great Lakes Advisors LLC Trims Position in CVS Health Corporation $CVS - MarketBeat
Cutler Investment Counsel LLC Buys 20,825 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Can Keep Trial Win In Cooler Injury Case, 7th Circ. Says - Law360
Dollar Tree takes over closed CVS Pharmacy near Jacksonville University - Jacksonville Daily Record
Aetna Launches Aetna Mental Health on Demand To Provide Real Time Access to Care and Ongoing Support - ACCESS Newswire
Cantor Fitzgerald reiterates CVS Health stock Overweight rating - Investing.com
Patients Denied Care, Then Approved Later? Federal Watchdog Raises Medicare Advantage Concerns - Benzinga
Cantor Fitzgerald reiterates CVS Health stock Overweight rating By Investing.com - Investing.com Canada
CVS Faces Scrutiny Over Medicare Advantage Denials - GuruFocus
CVS Health Corporation $CVS Shares Sold by Townsquare Capital LLC - MarketBeat
Illinois Municipal Retirement Fund Purchases 62,717 Shares of CVS Health Corporation $CVS - MarketBeat
Deutsche Bank AG Acquires 1,031,998 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Cerity Partners LLC - MarketBeat
CVS Health (NYSE:CVS) Sets New 12-Month HighHere's What Happened - MarketBeat
Musab Balbale Departs CVS Health; Zach Dennett Named Interim Merchandising Leader - Yahoo Finance
CVS Health stock hits 52-week high at 98.44 USD - Investing.com India
CVS Health expands GLP-1 coverage, adds Zepbound to formulary - Investing.com
CVS Health expands GLP-1 coverage, adds Zepbound to formulary By Investing.com - Investing.com Canada
CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications With Expanded Coverage Options - marketscreener.com
CVS Health Corporation $CVS Shares Bought by Motley Fool Asset Management LLC - MarketBeat
Franklin Resources Inc. Sells 3,438,834 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Purchased by Erste Asset Management GmbH - MarketBeat
Brandes Investment Partners LP Acquires 45,860 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Offers A Compelling Turnaround Opportunity Not Seen In Years (NYSE:CVS) - Seeking Alpha
CVS Stock Quote Price and Forecast - CNN
Bullish on CVS Health Corp. - The Globe and Mail
CVS Health (CVS) Valuation Check As GLP 1 Access Expands And PBM Scrutiny Intensifies - Yahoo Finance
CVS Health Recognized for Technology That Improves Medication Safety and Patient Care - marketscreener.com
Aetna Better Health of Missouri, community orgs expand access to maternal care in rural communities - Drug Store News
O Shaughnessy Asset Management LLC Buys 32,536 Shares of CVS Health Corporation $CVS - MarketBeat
How CVS Generates Revenue: A Look at Their Business Model - Investopedia
MML Income & Growth Fund's CVS Health Corp(CVS) Holding History - GuruFocus
CVS Pharmacy retail stores as everyday health hubs in the US - AD HOC NEWS
CVS launched an AI Learning Academy for its workers. Here's why - Fierce Healthcare
CVS Maintained by Mizuho -- Price Target Raised to $115 - GuruFocus
CVS Health stock (US1266501006): What investors are watching now - AD HOC NEWS
CVS Health (CVS): One of the Best Blue Chip Stocks Under $100 to Buy Now - Insider Monkey
WNC man sentenced in CVS Pharmacy robbery, drug trafficking case - WSPA 7NEWS
UBS Group Issues Positive Forecast for CVS Health (NYSE:CVS) Stock Price - MarketBeat
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):